Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma. Recommendation based on IMROZ phase 3 study demonstrating Sarclis ...
Akebia Therapeutics®, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the American Journal of Kidney Disease has ...
BY REUTERS More than 61,000 people are estimated to have died in Khartoum state during the first 14 months of Sudan's war, with evidence suggesting the toll from the devastating conflict is ...
Despite this ruling Council Leader - Carl Les - says the company have now said they will undertake an environmental study. Europa's decision to voluntarily undertake an environmental assessment has ...
Beginning in early 2024, the UK government implemented changes to certain visa routes and released significant revisions to its Immigration Rules as part of efforts to reduce net migration levels.
Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery ...